Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Tonix Pharmaceuticals Holding Corp. - Common Stock (NQ:TNXP)

28.00 +4.90 (+21.21%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,537,795
Open 25.17
Bid (Size) 27.45 (8)
Ask (Size) 27.90 (1)
Prev. Close 23.10
Today's Range 25.02 - 30.20
52wk Range 6.760 - 672.00
Shares Outstanding 7,324,670
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The market is filled with gapping stocks in Friday's session.
Let's delve into the US markets on Friday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks. 
Via Chartmill
Tonix Pharmaceuticals (TNXP) Stock Surges Following Insider Buying And Q1 Results
Tonix stock surged over 33% this week fueled by insider buying and strong Q1 results. The company's Q1 loss beat estimates. 
Via Benzinga

Performance

YTD
-10.8%
-10.8%
1 Month
+64.7%
+64.7%
3 Month
+145.0%
+145.0%
6 Month
+100.0%
+100.0%
1 Year
-95.2%
-95.2%

More News

Read More
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Tonix Pharma Stock Soars After Roping In Former Celgene Corp Executive Joseph Hand: Retail Gets More Positive
Via Stocktwits
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Appoints Joseph Hand as General Counsel and EVP of Operations
Via Investor Brand Network
Exposures Product Safety
TechMediaBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Prepares for Potential Fibromyalgia Drug Approval, Reports Q1 Results
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Positive Preclinical Data for TNX-1700 at AACR 2025
Via Investor Brand Network
Exposures Product Safety
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Showcases Single-Dose Mpox Vaccine Data at World Vaccine Congress
Via Investor Brand Network
Exposures Product Safety
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Collaborates With Makana Therapeutics on Xenotransplantation Research
Via Investor Brand Network
Exposures Product Safety
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Positive Data on Fibromyalgia Drug at AAPM 2025
Via Investor Brand Network
Exposures Product Safety
Peering Into Tonix Pharmaceuticals's Recent Short Interest
Via Benzinga
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) CEO to Present at 2025 Jones Trading Healthcare Conference
Via Investor Brand Network
Exposures Product Safety
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Launches TONIX ONE™ Digital Platform to Transform Migraine Care
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Advances Non-Opioid Fibromyalgia Drug Toward FDA Decision
Via Investor Brand Network
Exposures Product Safety
Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year
Via ACCESS Newswire
New to The Street Show #639 Premieres Nationwide on Bloomberg Television, March 29 at 6:30 PM EST Featuring BioVie, Roadzen, Tonix Pharma, and eXoZymes Inc.
Via ACCESS Newswire
What's Going On With Tonix Pharmaceuticals (TNXP) Stock?
Via Benzinga
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present at AAPM 2025 PainConnect Meeting
Via Investor Brand Network
Exposures Product Safety
Pharma Frenzy: Volatility Ignites Biotech Sector
Via MarketBeat
Exposures Product Safety
Top 2 Health Care Stocks That Are Ticking Portfolio Bombs
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Traders are paying attention to the gapping stocks in Monday's session.
Via Chartmill
Discover the top movers in Monday's pre-market session.
Via Chartmill
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Advances Fibromyalgia Drug Without Advisory Committee Review
Via Investor Brand Network
Exposures Product Safety
Why Tonix Pharmaceuticals (TNXP) Stock Is Rising
Via Benzinga
Exposures Product Safety

Frequently Asked Questions

Is Tonix Pharmaceuticals Holding Corp. - Common Stock publicly traded?
Yes, Tonix Pharmaceuticals Holding Corp. - Common Stock is publicly traded.
What exchange does Tonix Pharmaceuticals Holding Corp. - Common Stock trade on?
Tonix Pharmaceuticals Holding Corp. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Tonix Pharmaceuticals Holding Corp. - Common Stock?
The ticker symbol for Tonix Pharmaceuticals Holding Corp. - Common Stock is TNXP on the Nasdaq Stock Market
What is the current price of Tonix Pharmaceuticals Holding Corp. - Common Stock?
The current price of Tonix Pharmaceuticals Holding Corp. - Common Stock is 28.00
When was Tonix Pharmaceuticals Holding Corp. - Common Stock last traded?
The last trade of Tonix Pharmaceuticals Holding Corp. - Common Stock was at 05/16/25 04:00 PM ET
What is the market capitalization of Tonix Pharmaceuticals Holding Corp. - Common Stock?
The market capitalization of Tonix Pharmaceuticals Holding Corp. - Common Stock is 205.09M
How many shares of Tonix Pharmaceuticals Holding Corp. - Common Stock are outstanding?
Tonix Pharmaceuticals Holding Corp. - Common Stock has 205M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.